We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+4.81%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$86.8M
AUM Growth
-$18.6M
Cap. Flow
-$3.59M
Cap. Flow %
-4.13%
Top 10 Hldgs %
34.84%
Holding
103
New
20
Increased
22
Reduced
25
Closed
29

Top Buys

Rank Stock Value
1
ALNA
Allena Pharmaceuticals
ALNA
+$7.09M
2
BIDU icon
Baidu
BIDU
+$2.46M
3
ZBH icon
Zimmer Biomet
ZBH
+$1.67M
4
CME icon
CME Group
CME
+$1.46M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.44M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$2.37M
2
JD icon
JD.com
JD
+$1.84M
3
ELV icon
Elevance Health
ELV
+$1.77M
4
AGN.PRA
Allergan plc
AGN.PRA
+$1.76M
5
CNC icon
Centene
CNC
+$1.61M

Sector Composition

Rank Sector Weight
1 Healthcare 60.42%
2 Technology 16.05%
3 Miscellaneous 9.04%
4 Communication Services 6.34%
5 Financials 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNNA
1
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$5.07M 5.84%
300,911
-29
-0% -$613
ALNA
2
DELISTED
Allena Pharmaceuticals
ALNA
$4.72M 5.44%
+575,407
New +$7.09M
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$4.14M 4.77%
85,117
+3,548
+4% +$179K
PBYI icon
4
Puma Biotechnology
PBYI
$468M
$2.61M 3%
26,369
+5,075
+24% +$568K
GDDY icon
5
GoDaddy
GDDY
$12.4B
$2.54M 2.92%
50,419
-7,672
-13% -$364K
BIDU icon
6
Baidu
BIDU
$32.9B
$2.35M 2.71%
+10,053
New +$2.46M
CRM icon
7
Salesforce
CRM
$211B
$2.18M 2.51%
21,339
-936
-4% -$95.4K
EW icon
8
Edwards Lifesciences
EW
$52B
$2.14M 2.46%
56,880
-12,387
-18% -$455K
ABT icon
9
Abbott
ABT
$195B
$2.1M 2.42%
36,766
-3,122
-8% -$173K
AERI
10
DELISTED
Aerie Pharmaceuticals
AERI
$2.01M 2.32%
33,688
+1,986
+6% +$120K
NOW icon
11
ServiceNow
NOW
$150B
$1.78M 2.05%
68,320
+6,870
+11% +$171K
BAX icon
12
Baxter International
BAX
$13.5B
$1.75M 2.01%
27,047
-9,336
-26% -$600K
UNH icon
13
UnitedHealth
UNH
$353B
$1.74M 2.01%
7,908
+1,147
+17% +$243K
ZBH icon
14
Zimmer Biomet
ZBH
$19.2B
$1.73M 1.99%
+14,767
New +$1.67M
BABA icon
15
Alibaba
BABA
$296B
$1.61M 1.85%
9,328
+855
+10% +$153K
DVA icon
16
DaVita
DVA
$11.5B
$1.59M 1.83%
+22,021
New +$1.36M
BOX icon
17
Box
BOX
$4.8B
$1.56M 1.8%
74,119
+6,541
+10% +$138K
HUM icon
18
Humana
HUM
$46.3B
$1.55M 1.79%
6,252
+1,791
+40% +$442K
MOH icon
19
Molina Healthcare
MOH
$10.4B
$1.54M 1.78%
20,105
+5,908
+42% +$426K
QQQ icon
20
PUT
Invesco QQQ Trust
QQQ
$489B
$1.54M 1.78%
9,900
-46,700
-83% -$7.13M
CME icon
21
CME Group
CME
$103B
$1.49M 1.72%
+10,230
New +$1.46M
XBI icon
22
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$1.39M 1.6%
+16,400
New +$1.37M
HCA icon
23
HCA Healthcare
HCA
$90.5B
$1.36M 1.57%
+15,535
New +$1.25M
REGN icon
24
Regeneron Pharmaceuticals
REGN
$81.8B
$1.34M 1.54%
+3,555
New +$1.44M
PYPL icon
25
PayPal
PYPL
$45.9B
$1.33M 1.53%
18,019
+413
+2% +$29.9K
1
2 3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Partner Investment Management held 103 positions worth $86.8M, down 18% from $105M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Partner Investment Management withdrew a net $3.59M in Q4 2017, closing 29 positions and reducing 25 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $2.37M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 43% a quarter earlier, followed by Technology and Miscellaneous.

Against the trend, Partner Investment Management opened a new position in Allena Pharmaceuticals worth $4.72M.

  • Partner Investment Management's largest Q4 2017 buy was Allena Pharmaceuticals: 575,407 shares worth $4.72M.
  • Partner Investment Management added most to Puma Biotechnology in Q4 2017, an estimated $568K increase.
  • Partner Investment Management's biggest Q4 2017 reduction was Elevance Health, cutting an estimated $1.77M.
  • Partner Investment Management fully exited Meta Platforms (Facebook) in Q4 2017, selling an estimated $2.37M.
  • Partner Investment Management's ten largest holdings make up 35% of its $86.8M portfolio in Q4 2017.
  • Partner Investment Management opened 20 new positions and closed 29 in Q4 2017.
  • Partner Investment Management's portfolio value fell 18% quarter-over-quarter to $86.8M.

Based on Partner Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.